Potential plasma lipid biomarkers in early-stage breast cancer

Ackerstaff E, Glunde K, Bhujwalla ZM (2003) Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90:525–533

Alokail MS, Al-Daghri N, Abdulkareem A, Draz HM, Yakout SM, Alnaami AM, Sabico S, Alenad AM, Chrousos GP (2013) Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk? BMC Cancer 13:54

Astley SM (2004) Computer-based detection and prompting of mammographic abnormalities. Br J Radiol 77(supp2):S194–S200

Brockmöller SF, Bucher E, Müller BM, Budczies J et al (2012) Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res 11:850–860

Budczies J, Denkert C, Müller BM, Brockmöller SF et al (2012) Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue—a GC-TOFMS based metabolomics study. BMC Genom 13:334

Budczies J, Pfitzner BM, Györffy B, Winzer KJ, Radke C, Dietel M, Fiehn O, Denkert C (2015) Glutamate enrichment as new diagnostic opportunity in breast cancer: glutamate and glutamine in breast cancer. Int J Cancer 136:1619–1628

Chan DW, Beveridge RA, Muss H, Fritsche HA, Hortobagyi G, Theriault R, Kiang D, Kennedy BJ, Evelegh M (1997) Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. J Clin Oncol 15:2322–2328

Chen X, Chen H, Dai M, Ai J, Li Y, Mahon B, Dai S, Deng Y (2016) Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions. Oncotarget 7:36622–36631

Cifkova E, Holcapek M, Lisa M, Vrana D, Melichar B, Student V (2015) Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. J Chromatogr, B: Anal Technol Biomed Life Sci 1000:14–21

Cummings BS, McHowat J, Schnellmann RG (2000) Phospholipase A(2)s in cell injury and death. J Pharmacol Exp Ther 294:793–799

Deacon EM, Pettitt TR, Webb P, Cross T, Chahal H, Wakelam MJ, Lord JM (2002) Generation of diacylglycerol molecular species through the cell cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-beta II at G2/M. J Cell Sci 115:983–989

Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18:54–61

Denizot Y, De Armas R, Caire F, Pommepuy I, Truffinet V, Labrousse F (2006) Platelet-activating factor and human meningiomas. Neuropathol Appl Neurobiol 32:674–678

Dunn WB, Broadhurst D, Begley P, Zelena E et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6:1060–1083

Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (2003) The case for early detection. Nat Rev Cancer 3:243–252

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, ParkinDM Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel members (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 24:2206–2223

Gross RW, Han X (2011) Lipidomics at the interface of structure and function in systems biology. Chem Biol 18:284–291

Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622–634

Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SO (2009) Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil. Cancer Chemother Pharmacol 63:691–701

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

Hilvo M, Denkert C, Lehtinen L, Müller B et al (2011) Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71:3236–3245

Kester MB, Sokolove PM (1990) The effect of adriamycin and duramycin on calcium translocation in liposome systems modeled on the inner mitochondrial membrane. Arch Biochem Biophys 280:405–411

Laye JP, Gill JH (2003) Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 8:710–716

Li YL, Su X, Stahl PD, Gross ML (2007) Quantification of diacylglycerol molecular species in biological samples by electrospray ionization mass spectrometry after one-step derivatization. Anal Chem 79:1569–1574

Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763–777

Molina R, Barak V, van Dalen A, Duffy MJ et al (2005) Tumor markers in breast cancer-European Group on Tumor Markers recommendations. Tumour Biol 26:281–293

More TH, Bagadi M, RoyChoudhury S, Dutta M et al (2017) Comprehensive quantitative lipidomic approach to investigate serum phospholipid alterations in breast cancer. Metabolomics 13:3

Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484–496

Notarnicola M, Altomare DF, Correale M, Ruggieri E, D’Attoma B, Mastrosimini A, Guerra V, Caruso MG (2005) Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology 68:371–374

Potischman N, McCulloch CE, Byers T, Houghton L, Nemoto T, Graham S, Campbell TC (1991) Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer 15:205–215

Qiu Y, Zhou B, Su M, Baxter S, Zheng X, Zhao X, Yen Y, Jia W (2013) Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. Int J Mol Sci 14:8047–8061

Walker JM, Krey JF, Chen JS, Vefring E, Jahnsen JA, Bradshaw H, Huang SM (2005) Targeted lipidomics: fatty acid amides and pain modulation. Prostaglandins Other Lipid Mediat 77:35–45

Want EJ, Masson P, Michopoulos F, Wilson ID, Theodoridis G, Plumb RS, Shockcor J, Loftus N, Holmes E, Nicholson JK (2013) Global metabolic profiling of animal and human tissues via UPLC–MS. Nat Protoc 8:17–32

Warner E (2011) Clinical practice. Breast-cancer screening. N Engl J Med 365:1025–1032

Yamashita S, Yamashita J, Sakamoto K, Inada K, Nakashima Y, Murata K, Saishoji T, Nomura K, Ogawa M (1993) Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells. Cancer 71:3058–3064

Yamashita J, Ogawa M, Sakai K (1995) Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 117:601–608

Yang L, Cui X, Zhang N, Li M, Bai Y, Han X, Shi Y, Liu H (2015) Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers. Anal Bioanal Chem 407:5065–5077

Yano K (2012) Lipid metabolic pathways as lung cancer therapeutic targets: a computational study. Int J Mol Med 29:519–529

You JC, Yang J, Fang RP, Hu N, Zhang XD, Zhang WY, Ye LH (2015) Analysis of phosphatidylcholines (PCs) and lysophosphatidylcholines (LysoPCs) in metastasis of breast cancer cells. Prog Biochem Biophys 42:563–573

Zhang GM, Qin XJ, Zhang HL, Xiao WJ, Zhu Y, Gu CY, Dai B, Shi GH, Ye DW (2015) Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy. Asian J Androl 17:239–244